{"abstract": "Sanofi proposed to Genzyme\u2019s board paying about $69 a share, people briefed on the matter told DealBook.", "web_url": "https://dealbook.nytimes.com/2010/08/02/sanofi-and-genzyme-open-merger-talks/", "snippet": "Sanofi proposed to Genzyme\u2019s board paying about $69 a share, people briefed on the matter told DealBook.", "lead_paragraph": "8:46 a.m. | Updated As Sanofi-Aventis begins holding merger negotiations with Genzyme \u2014 after sending a letter outlining a potential takeover worth up to $18.4 billion, people briefed on the matter told DealBook on Monday \u2014 the French drug maker will have challenges to contend with.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Challenges Await Sanofi as Genzyme Talks Begin", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Icahn, Carl C", "rank": 1, "major": "N"}, {"name": "persons", "value": "Whitworth, Ralph V", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis SA", "rank": 4, "major": "N"}], "pub_date": "2010-08-02T23:59:06+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/11f4fc88-7e98-5b9c-b975-e283d1e895f4", "word_count": 363, "uri": "nyt://article/11f4fc88-7e98-5b9c-b975-e283d1e895f4"}